(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 and come into force on 1st April 2023.
(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.
資料由法律人 LawPlayer整理提供·UK legislation / curated by LawPlayer from legislation.gov.uk
(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 and come into force on 1st April 2023.
(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.
(1) Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.
(2) In paragraph (1), for the table substitute—
Table
(3) In paragraph (1B)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023” ,
(b) for “17.7%” substitute “28.6%” , and
(c) for “14.3%” substitute “27.5%” .
(4) In paragraph (1C)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023” ,
(b) in sub-paragraph (a)—
(i) for “1st January 2022” substitute “1st January 2023” , and
(ii) for “30th June 2022” substitute “31st March 2023” , and
(c) in sub-paragraph (b), for “10.9%” substitute “24.4%” .
The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023 (legislation.gov.uk, OGL v3.0). Retrieved via LawPlayer, https://lawplayer.com/uk/act/uksi-2023-239
Contains public sector information licensed under the Open Government Licence v3.0.
本頁資料來源:legislation.gov.uk (The National Archives)·整理提供:法律人 LawPlayer· lawplayer.com